|
시장보고서
상품코드
1671860
인간 1차 세포 배양 시장 : 제품 유형별, 세포 유형별, 용도별, 최종사용자별Human Primary Cell Culture Market, By Product Type, By Cell Type, By Application, By End User |
||||||
인간 1차 세포 배양 세계 시장은 2025년에 41억 달러, 2032년에는 86억 1,000만 달러에 달할 것으로 예상되며, 2025년부터 2032년까지 연평균 11.2%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 예상됩니다.
| 보고 범위 | 보고서 상세 내용 | ||
|---|---|---|---|
| 기준 연도 | 2024년 | 2025년 시장 규모 | 41억 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2025-2032년 |
| 예측 기간(2025-2032년) CAGR | 11.2% | 2032년 가치 예측 | 86억 1,000만 달러 |
인간 원시세포 배양은 인위적으로 통제된 환경에서 체내에서 직접 추출한 인간 세포나 조직을 배양하는 것을 말합니다. 지난 수십년동안 인간 원시세포를 분리하고 배양하는 기술은 크게 발전했습니다. 1차 세포 배양을 통해 연구자들은 개별 세포 유형과 다양한 자극에 대한 반응을 생체 외부의 접시 안에서 연구할 수 있습니다. 이를 통해 동물이나 인간 피험자의 사용을 줄이면서 질병 과정에 대한 통찰력을 얻고 잠재적인 치료제를 시험할 수 있습니다. 원시세포는 유래한 생체 내 특정 세포의 특징을 유지하며, 생체 내 세포와 유사한 신진대사를 가지고 있습니다. 세계 인간 1차 세포 배양 시장은 암, 줄기세포, 조직공학, 신약개발과 관련된 연구에 광범위하게 적용되면서 견인력을 얻고 있습니다.
시장 역학:
세계 인간 1차 세포 배양 시장은 의약품 연구개발 활동의 활성화, 헬스케어 연구에 대한 정부 지출 증가, 만성질환의 확산에 의해 주도되고 있습니다. 1차 세포 배양은 암과 같은 다양한 질병에 대한 맞춤형 의약품 개발에 중요한 역할을 하고 있습니다. 그러나 분리 절차의 높은 비용과 세포 배양 실험실의 인프라 요구 사항으로 인해 시장 성장을 제한하고 있습니다. 1차 세포를 다루는 숙련된 전문가의 부족도 문제점으로 지적되고 있습니다. 긍정적인 측면에서는 생체 내 미세 환경을 더 잘 모방하는 배양 배지 배합의 기술 발전이 기회를 제공하고 있으며, 3D 바이오 프린팅 기술 개발 및 1차 세포를 이용한 장기 온칩 플랫폼의 개발은 예측 기간 동안 시장 확대를 더욱 촉진할 것으로 보입니다.
본 조사의 주요 특징
이 보고서는 2024년을 기준 연도로 하여 예측 기간(2025-2032년) 시장 규모와 연평균 성장률(CAGR%)을 분석하여 세계 인간 1차 세포 배양 시장에 대해 조사 분석한 보고서입니다.
또한, 다양한 부문에 걸친 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 중요한 고찰을 제공합니다.
세계 인간 1차세포배양 시장의 주요 기업 프로파일을 기업 개요, 제품 포트폴리오, 주요 특징, 실적, 전략 등의 파라미터를 기준으로 정리하여 수록하였습니다.
본 조사 대상의 주요 기업으로는 Thermo Fisher Scientific,Merck KGaA,Lonza Group,Danaher Corporation,Becton,Dickinson and Company,Corning Incorporated,Sartorius AG,GE Healthcare,Fujifilm Irvine Scientific,Sigma-Aldrich(Merck),PromoCell GmbH,ATCC(American Type Culture Collection),Cell Biologics,InVivo Biosystems, Stemcell Technologies 등이 있습니다.
이 보고서에서 얻은 통찰력을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 유형 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
이 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
이해관계자들은 세계 인간 1차 세포 배양 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있습니다.
목차
제1장 조사 목적과 전제조건
- 조사 목적
- 전제조건
- 약어
제2장 시장 전망
- 보고서 설명
- 시장 정의와 범위
- 주요 요약
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 성장 촉진요인
- 성장 억제요인
- 기회
- 영향 분석
- 주요 발전
- 규제 시나리오
- 제품 발매/승인
- PEST 분석
- PORTER 분석
- 인수합병(M&A) 시나리오
- 업계 동향
제4장 세계의 인간 1차 세포 배양 시장, 제품 유형별, 2020년-2032년
- 1차 세포
- 기계
- 시약 및 보충제
- 1차 세포 배양 배지
- 기타 소모품
제5장 세계의 인간 1차 세포 배양 시장, 세포 유형별, 2020년-2032년
- 인간 1차 세포
- 동물 1차 세포
제6장 세계의 인간 1차 세포 배양 시장, 용도별, 2020년-2032년
- 세포 및 유전자 치료 개발
- 백신 제조
- Drug Discovery & Development
- 암 연구
- 산전 진단
- 기타
제7장 세계의 인간 1차 세포 배양 시장, 최종사용자별, 2020년-2032년
- 제약 기업 및 바이오테크놀러지 기업
- 학술연구기관
- 계약연구기관(CRO)
- 기타
제8장 세계의 인간 1차 세포 배양 시장, 지역별, 2020년-2032년
- 북미
- 라틴아메리카
- 유럽
- 아시아태평양
- 중동
- 아프리카
제9장 경쟁 구도
- Thermo Fisher Scientific
- Merck KGaA
- Lonza Group
- Danaher Corporation
- Becton, Dickinson and Company
- Corning Incorporated
- Sartorius AG
- GE Healthcare
- Fujifilm Irvine Scientific
- Sigma-Aldrich(Merck)
- PromoCell GmbH
- ATCC(American Type Culture Collection)
- Cell Biologics
- InVivo Biosystems
- Stemcell Technologies
제10장 애널리스트 추천 사항
- Wheel of Fortune
- 애널리스트의 견해
- COM(Coherent Opportunity Map)
제11장 참고 문헌과 조사 방법
- 참고 문헌
- 조사 방법
- 출판사에 대해
The Global Human Primary Cell Culture Market is estimated to be valued at USD 4.10 Bn in 2025 and is expected to reach USD 8.61 Bn by 2032 exhibiting a compound annual growth rate (CAGR) of 11.2% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 4.10 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 11.20% | 2032 Value Projection: | USD 8.61 Bn |
Human primary cell culture refers to the practice of growing human cells and tissues directly extracted from the body in an artificial controlled environment. Over the past few decades, techniques of isolating and culturing primary human cells have advanced significantly. Primary cell cultures allow researchers to study individual cell types and their responses to various stimuli in a dish, outside a living organism. This reduces the use of animal and human subjects in research while providing insights into disease processes and testing potential therapeutic agents. Primary cells retain characteristics of the specific cell in the body from which they are derived and have metabolism resembling their in vivo counterparts. The global human primary cell culture market has been gaining traction due to its wide application in research related to cancer, stem cells, tissue engineering, and drug discovery.
Market Dynamics:
The global human primary cell culture market is driven by rising pharmaceutical R&D activities, increasing governmental expenditure on healthcare research, and growing prevalence of chronic diseases. Primary cell culture plays a critical role in developing personalized medicines for various conditions like cancer. However, high cost of isolation procedures and infrastructure requirements for cell culture laboratories limit the market growth. Shortage of skilled professionals to handle primary cells also poses a challenge. On the positive side, technological advancements in culture media formulations that better mimic the in vivo microenvironment offer opportunities. Adoption of 3D bioprinting techniques and development of organ-on-chip platforms utilizing primary cells would further support the market expansion during the forecast period.
Key Features of the Study:
This report provides in-depth analysis of the global human primary cell culture market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global human primary cell culture market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Thermo Fisher Scientific, Merck KGaA, Lonza Group, Danaher Corporation, Becton, Dickinson and Company, Corning Incorporated, Sartorius AG, GE Healthcare, Fujifilm Irvine Scientific, Sigma-Aldrich (Merck), PromoCell GmbH, ATCC (American Type Culture Collection), Cell Biologics, InVivo Biosystems, and Stemcell Technologies
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global human primary cell culture market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global human primary cell culture market
Market Segmentation
- Product Type Insights (Revenue, USD Bn, 2020 - 2032)
- Primary Cells
- Instruments
- Reagents and Supplements
- Primary Cell Culture Media
- Other Consumables
- Cell Type Insights (Revenue, USD Bn, 2020 - 2032)
- Human Primary Cells
- Animal Primary Cells
- Application Insights (Revenue, USD Bn, 2020 - 2032)
- Cell & Gene Therapy Development
- Vaccine Production
- Drug Discovery and Development
- Cancer Research
- Prenatal Diagnosis
- Others
- End User Insights (Revenue, USD Bn, 2020 - 2032)
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutions
- Contract Research Organizations (CROs)
- Others
- Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Thermo Fisher Scientific
- Merck KGaA
- Lonza Group
- Danaher Corporation
- Becton, Dickinson and Company
- Corning Incorporated
- Sartorius AG
- GE Healthcare
- Fujifilm Irvine Scientific
- Sigma-Aldrich (Merck)
- PromoCell GmbH
- ATCC (American Type Culture Collection)
- Cell Biologics
- InVivo Biosystems
- Stemcell Technologies
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Human Primary Cell Culture Market, By Product Type
- Global Human Primary Cell Culture Market, By Cell Type
- Global Human Primary Cell Culture Market, By Application
- Global Human Primary Cell Culture Market, By End User
- Global Human Primary Cell Culture Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Human Primary Cell Culture Market, By Product Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Primary Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Instruments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Reagents and Supplements
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Primary Cell Culture Media
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Other Consumables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5. Global Human Primary Cell Culture Market, By Cell Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Human Primary Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Animal Primary Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Human Primary Cell Culture Market, By Application, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Cell & Gene Therapy Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Vaccine Production
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Drug Discovery and Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Cancer Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Prenatal Diagnosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Human Primary Cell Culture Market, By End User, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Academic and Research Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Contract Research Organizations (CROs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Human Primary Cell Culture Market, By Region, 2020 - 2032, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product Type , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Cell Type , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product Type , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Cell Type , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product Type , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Cell Type , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Cell Type , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product Type , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Cell Type , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product Type , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Cell Type , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
9. Competitive Landscape
- Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck KGaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Lonza Group
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Danaher Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Becton, Dickinson and Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Corning Incorporated
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sartorius AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GE Healthcare
- Fujifilm Irvine Scientific
- Sigma-Aldrich (Merck)
- PromoCell GmbH
- ATCC (American Type Culture Collection)
- Cell Biologics
- InVivo Biosystems
- Stemcell Technologies
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us
